Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.8400
-1.1600
(-23.20%)
At close: February 28 at 3:26:29 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ADLER YARON Director | Conversion of Exercise of derivative security | Jun 11, 2018 | -- |
| BELENGER OLIVIER Shareholder | Sale | Oct 11, 2017 | -- |
| BULTOT HUGUES Director | Conversion of Exercise of derivative security | Nov 17, 2017 | 7,127,090 |
| CAPLAN VERED Chief Executive Officer | Conversion of Exercise of derivative security | Jan 28, 2022 | 278,191 |
| MILLER VICTOR Chief Financial Officer | Conversion of Exercise of derivative security | Apr 1, 2024 | 25,000 |
| SAFIER JACOB Beneficial Owner of more than 10% of a Class of Security | Purchase | Jun 24, 2024 | -- |
| SIDRANSKY DAVID Director | Purchase | May 20, 2020 | -- |
| THEODORUS II SA Shareholder | Sale | Oct 11, 2017 | -- |
| THEODORUS SCA Shareholder | Sale | Oct 11, 2017 | -- |
| UNIVERSITE LIBRE DE BRUXELLES Shareholder | Sale | Nov 17, 2017 | 408,792 |
Related Tickers
PYPD PolyPid Ltd.
3.2300
+9.86%
GTBP GT Biopharma, Inc.
2.3800
+3.48%
PSTV Plus Therapeutics, Inc.
0.7250
+7.41%
CHRO Channel Therapeutics Corporation
2.0500
0.00%
BRTX BioRestorative Therapies, Inc.
1.5200
-6.17%
PBM Psyence Biomedical Ltd.
1.2400
0.00%
SCPX Scorpius Holdings, Inc.
0.1710
+8.85%
VINC Vincerx Pharma, Inc.
1.0900
-13.49%
TNFA TNF Pharmaceuticals, Inc.
0.4181
-2.70%
REVB Revelation Biosciences, Inc.
3.4900
-1.41%